Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to see if RAD001 can help to control the disease
in patients with systemic mastocytosis (SM). The safety of this treatment will also be
studied.